Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hormone abuse in sport

D L Russell-Jones¹

¹Department of Diabetes and Endocrinology, Royal Surrey County Hospital, Guildford, UK. d.russell-jones@surrey.ac.uk

Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society

|August 3, 1999

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

USA joins Canada, UK, Ireland and Austria in allowing people with insulin-treated diabetes to fly commercial aircraft.

Diabetic medicine : a journal of the British Diabetic Association·2020

Same author

SGLT2 inhibitors in Type 1 diabetes: is this the future?

Diabetic medicine : a journal of the British Diabetic Association·2018

Same author

Hepato-preferential insulins: Is this the end, or the end of the beginning?

Diabetes, obesity & metabolism·2016

Same author

Effect of subcutaneous insulin detemir on glucose flux, lipolysis and electroencephalography in type 1 diabetes.

Diabetes, obesity & metabolism·2015

Same author

Effect of subcutaneous insulin detemir on glucose flux and lipolysis during hyperglycaemia in people with type 1 diabetes.

Diabetes, obesity & metabolism·2015

Same author

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial.

Diabetic medicine : a journal of the British Diabetic Association·2013